Poseida Therapeutics Stock Number Of Employees
Poseida Therapeutics fundamentals help investors to digest information that contributes to Poseida Therapeutics' financial success or failures. It also enables traders to predict the movement of Poseida Stock. The fundamental analysis module provides a way to measure Poseida Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Poseida Therapeutics stock.
Poseida |
Poseida Therapeutics Company Number Of Employees Analysis
Poseida Therapeutics' Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current Poseida Therapeutics Number Of Employees | 350 |
Most of Poseida Therapeutics' fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Poseida Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
CompetitionBased on the recorded statements, Poseida Therapeutics is currently employing 350 people. This is 96.82% lower than that of the Biotechnology sector and 34.62% lower than that of the Health Care industry. The number of employees for all United States stocks is 98.14% higher than that of the company.
Poseida Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Poseida Therapeutics' direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Poseida Therapeutics could also be used in its relative valuation, which is a method of valuing Poseida Therapeutics by comparing valuation metrics of similar companies.Poseida Therapeutics is currently under evaluation in number of employees category among its peers.
Poseida Fundamentals
| Return On Equity | -0.58 | |||
| Return On Asset | -0.13 | |||
| Profit Margin | (0.40) % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 777.81 M | |||
| Shares Outstanding | 97.47 M | |||
| Shares Owned By Insiders | 27.64 % | |||
| Shares Owned By Institutions | 58.44 % | |||
| Number Of Shares Shorted | 3.59 M | |||
| Price To Earning | 214.00 X | |||
| Price To Book | 10.62 X | |||
| Price To Sales | 6.14 X | |||
| Revenue | 64.7 M | |||
| Gross Profit | (21.57 M) | |||
| EBITDA | (109.04 M) | |||
| Net Income | (123.43 M) | |||
| Cash And Equivalents | 142.56 M | |||
| Cash Per Share | 1.66 X | |||
| Total Debt | 85.42 M | |||
| Debt To Equity | 1.39 % | |||
| Current Ratio | 3.69 X | |||
| Book Value Per Share | 0.90 X | |||
| Cash Flow From Operations | (92.17 M) | |||
| Short Ratio | 1.49 X | |||
| Earnings Per Share | (0.63) X | |||
| Price To Earnings To Growth | (0.63) X | |||
| Target Price | 9.5 | |||
| Number Of Employees | 350 | |||
| Beta | 0.54 | |||
| Market Capitalization | 925.93 M | |||
| Total Asset | 273.88 M | |||
| Retained Earnings | (594.29 M) | |||
| Working Capital | 155.16 M | |||
| Current Asset | 10.59 M | |||
| Current Liabilities | 5.1 M | |||
| Net Asset | 273.88 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Poseida Stock
If you are still planning to invest in Poseida Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Poseida Therapeutics' history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |